Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

37.32
-0.0800-0.21%
Post-market: 37.320.00000.00%19:26 EDT
Volume:10.26M
Turnover:383.30M
Market Cap:166.63B
PE:9.32
High:37.65
Open:37.64
Low:37.17
Close:37.40
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.79
T/O Rate:0.32%
Dividend:1.79
Dividend Rate:4.78%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.12
PE(LYR):10.31

Loading ...

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

Novo Nordisk Kept at Hold as Analyst Maintains $47 Price Target Amid Strategic Uncertainty

TIPRANKS
·
Sep 14

Data Retention Terms Prompt Restraints on AI Model Use for Sensitive Operations

Deep News
·
Sep 14

Novo Signals New Direction of Travel with Rebrand

Dow Jones
·
Sep 14

AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales

Options & Short Sell
·
Sep 14

Novo Nordisk to Rebrand as Novo

Dow Jones
·
Sep 14

GE HealthCare Plans $1 Billion Sofie Deal To Tap Fast-Growing Radiopharmaceuticals Market

Options & Short Sell
·
Sep 14

Novo Nordisk Stock Slides as GLP-1 Fears Mount

TIPRANKS
·
Sep 12

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

ETF Weekly | MSTZ, SMST Surge 17%; AMUU, AMDL Jump 16%; USO Advances 9%; Oil Theme Gains

ETF Weekly
·
Sep 12

Sector Update: Healthcare

MT Newswires Live
·
Sep 12

Novo Nordisk Shares Fall After Morgan Stanley Downgrade

MT Newswires Live
·
Sep 12

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 12

U.S. Stocks on the MOVE-Novo Nordisk, Oracle, Adobe

Reuters
·
Sep 11

Novo Nordisk Stock (NVO) Falls After Morgan Stanley’s Sell Call on Market Share Loss to Eli Lilly, Patent Cliff

TIPRANKS
·
Sep 11

Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Sep 11

Morgan Stanley downgrades Novo Nordisk (0QIU) to a Sell

TIPRANKS
·
Sep 11

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Sep 11

Novo Nordisk’s CagriSema Trial Targets Painful Diabetic Nerve Damage

TIPRANKS
·
Sep 11